Simultaneous determination of chlordiazepoxide and clidinium bromide in pharmaceutical formulations by derivative spectrophotometry
Author
dc.contributor.author
Toral Ponce, María
Author
dc.contributor.author
Richter Duk, Pablo
Author
dc.contributor.author
Lara, Nelson
Author
dc.contributor.author
Jaque, Pablo
Author
dc.contributor.author
Soto, Cesar
Author
dc.contributor.author
Saavedra, Marcela
Admission date
dc.date.accessioned
2018-12-20T15:09:21Z
Available date
dc.date.available
2018-12-20T15:09:21Z
Publication date
dc.date.issued
1999
Cita de ítem
dc.identifier.citation
International Journal of Pharmaceutics, Volumen 189, Issue 1, 2018, Pages 67-74
Identifier
dc.identifier.issn
03785173
Identifier
dc.identifier.other
10.1016/S0378-5173(99)00238-0
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/158034
Abstract
dc.description.abstract
A direct and simple first derivative spectrophotometric method has been developed for the simultaneous determination of clidinium bromide and chlordiazepoxide in pharmaceutical formulations. Acetonitrile was used as solvent for extracting the drugs from the formulations and subsequently the samples were evaluated directly by derivative spectrophotometry. Simultaneous determination of the drugs can be carried out using the zero-crossing method for clidinium bromide at 220.8 nm and the graphical method for chlordiazepoxide at 283.6 nm. The calibration graphs were linear in the ranges from 0.983 to 21.62 mg/l of clidinium bromide and from 0.740 to 12.0 mg/l of chlordiazepoxide. The ingredients commonly found in commercial pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in tablets. Copyright (C) 1999 Elsevier Science B.V.